BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16480274)

  • 1. Potent 4-arylalkyl-substituted 3-isothiazolol GABA(A) competitive/noncompetitive antagonists: synthesis and pharmacology.
    Krehan D; Storustovu SI; Liljefors T; Ebert B; Nielsen B; Krogsgaard-Larsen P; Frølund B
    J Med Chem; 2006 Feb; 49(4):1388-96. PubMed ID: 16480274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent 4-aryl- or 4-arylalkyl-substituted 3-isoxazolol GABA(A) antagonists: synthesis, pharmacology, and molecular modeling.
    Frølund B; Jensen LS; Guandalini L; Canillo C; Vestergaard HT; Kristiansen U; Nielsen B; Stensbøl TB; Madsen C; Krogsgaard-Larsen P; Liljefors T
    J Med Chem; 2005 Jan; 48(2):427-39. PubMed ID: 15658856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel class of potent 4-arylalkyl substituted 3-isoxazolol GABA(A) antagonists: synthesis, pharmacology, and molecular modeling.
    Frølund B; Jørgensen AT; Tagmose L; Stensbøl TB; Vestergaard HT; Engblom C; Kristiansen U; Sanchez C; Krogsgaard-Larsen P; Liljefors T
    J Med Chem; 2002 Jun; 45(12):2454-68. PubMed ID: 12036354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of bicuculline/baclofen-insensitive (rho-like) gamma-aminobutyric acid receptors expressed in Xenopus oocytes. II. Pharmacology of gamma-aminobutyric acidA and gamma-aminobutyric acidB receptor agonists and antagonists.
    Woodward RM; Polenzani L; Miledi R
    Mol Pharmacol; 1993 Apr; 43(4):609-25. PubMed ID: 8386310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in kinetics of structurally related competitive GABA(A) receptor antagonists.
    Vestergaard HT; Cannillo C; Frølund B; Kristiansen U
    Neuropharmacology; 2007 Mar; 52(3):873-82. PubMed ID: 17125806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Substituted imidazole-4-acetic acid analogues: synthesis, modeling, and pharmacological characterization of a series of novel gamma-aminobutyric acid(C) receptor agonists.
    Madsen C; Jensen AA; Liljefors T; Kristiansen U; Nielsen B; Hansen CP; Larsen M; Ebert B; Bang-Andersen B; Krogsgaard-Larsen P; Frølund B
    J Med Chem; 2007 Aug; 50(17):4147-61. PubMed ID: 17655213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel 4-(piperidin-4-yl)-1-hydroxypyrazoles as gamma-aminobutyric acid(A) receptor ligands: synthesis, pharmacology, and structure-activity relationships.
    Møller HA; Sander T; Kristensen JL; Nielsen B; Krall J; Bergmann ML; Christiansen B; Balle T; Jensen AA; Frølund B
    J Med Chem; 2010 Apr; 53(8):3417-21. PubMed ID: 20355712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analogues of gamma-aminobutyric acid (GABA) and trans-4-aminocrotonic acid (TACA) substituted in the 2 position as GABAC receptor antagonists.
    Chebib M; Vandenberg RJ; Johnston GA
    Br J Pharmacol; 1997 Dec; 122(8):1551-60. PubMed ID: 9422798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurosteroid analogues. 14. Alternative ring system scaffolds: GABA modulatory and anesthetic actions of cyclopenta[b]phenanthrenes and cyclopenta[b]anthracenes.
    Scaglione JB; Jastrzebska I; Krishnan K; Li P; Akk G; Manion BD; Benz A; Taylor A; Rath NP; Evers AS; Zorumski CF; Mennerick S; Covey DF
    J Med Chem; 2008 Mar; 51(5):1309-18. PubMed ID: 18275132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Competitive antagonism of insect GABA receptors by 4-substituted 5-(4-piperidyl)-3-isothiazolols.
    Liu G; Furuta K; Nakajima H; Ozoe F; Ozoe Y
    Bioorg Med Chem; 2014 Sep; 22(17):4637-45. PubMed ID: 25112550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of novel 4-PIOL analogues at human alpha 1 beta 2 gamma 2S GABA(A) receptors--correlation with hydrophobicity.
    Mortensen M; Frølund B; Jørgensen AT; Liljefors T; Krogsgaard-Larsen P; Ebert B
    Eur J Pharmacol; 2002 Sep; 451(2):125-32. PubMed ID: 12231381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel, selective GABA(A) alpha5 receptor inverse agonist which enhances cognition.
    Chambers MS; Atack JR; Broughton HB; Collinson N; Cook S; Dawson GR; Hobbs SC; Marshall G; Maubach KA; Pillai GV; Reeve AJ; MacLeod AM
    J Med Chem; 2003 May; 46(11):2227-40. PubMed ID: 12747794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, structure-activity relationships at the GABA(A) receptor in rat brain, and differential electrophysiological profile at the recombinant human GABA(A) receptor of a series of substituted 1,2-diphenylimidazoles.
    Asproni B; Talani G; Busonero F; Pau A; Sanna S; Cerri R; Mascia MP; Sanna E; Biggio G
    J Med Chem; 2005 Apr; 48(7):2638-45. PubMed ID: 15801854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GABA(A) agonists and partial agonists: THIP (Gaboxadol) as a non-opioid analgesic and a novel type of hypnotic.
    Krogsgaard-Larsen P; Frølund B; Liljefors T; Ebert B
    Biochem Pharmacol; 2004 Oct; 68(8):1573-80. PubMed ID: 15451401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-phenyl-6-(2-pyridyl)methyloxy-1,2,4-triazolo[3,4-a]phthalazines and analogues: high-affinity gamma-aminobutyric acid-A benzodiazepine receptor ligands with alpha 2, alpha 3, and alpha 5-subtype binding selectivity over alpha 1.
    Carling RW; Moore KW; Street LJ; Wild D; Isted C; Leeson PD; Thomas S; O'Connor D; McKernan RM; Quirk K; Cook SM; Atack JR; Wafford KA; Thompson SA; Dawson GR; Ferris P; Castro JL
    J Med Chem; 2004 Mar; 47(7):1807-22. PubMed ID: 15027873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and binding affinity of 2-phenylimidazo[1,2-alpha]pyridine derivatives for both central and peripheral benzodiazepine receptors. A new series of high-affinity and selective ligands for the peripheral type.
    Trapani G; Franco M; Ricciardi L; Latrofa A; Genchi G; Sanna E; Tuveri F; Cagetti E; Biggio G; Liso G
    J Med Chem; 1997 Sep; 40(19):3109-18. PubMed ID: 9301675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of GABA(A) receptor partial agonists in primary cultures of cerebellar granule neurons and cerebral cortical neurons reflect different receptor subunit compositions.
    Hansen SL; Ebert B; Fjalland B; Kristiansen U
    Br J Pharmacol; 2001 Jun; 133(4):539-49. PubMed ID: 11399671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, in vitro affinity, and efficacy of a bis 8-ethynyl-4H-imidazo[1,5a]- [1,4]benzodiazepine analogue, the first bivalent alpha5 subtype selective BzR/GABA(A) antagonist.
    Li X; Cao H; Zhang C; Furtmueller R; Fuchs K; Huck S; Sieghart W; Deschamps J; Cook JM
    J Med Chem; 2003 Dec; 46(26):5567-70. PubMed ID: 14667209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of functionally selective 7,8,9,10-tetrahydro-7,10-ethano-1,2,4-triazolo[3,4-a]phthalazines as GABA A receptor agonists at the alpha3 subunit.
    Russell MG; Carling RW; Atack JR; Bromidge FA; Cook SM; Hunt P; Isted C; Lucas M; McKernan RM; Mitchinson A; Moore KW; Narquizian R; Macaulay AJ; Thomas D; Thompson SA; Wafford KA; Castro JL
    J Med Chem; 2005 Mar; 48(5):1367-83. PubMed ID: 15743180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of the pharmacophore model for 5-HT7R antagonism. Design and synthesis of new naphtholactam and naphthosultam derivatives.
    López-Rodríguez ML; Porras E; Morcillo MJ; Benhamú B; Soto LJ; Lavandera JL; Ramos JA; Olivella M; Campillo M; Pardo L
    J Med Chem; 2003 Dec; 46(26):5638-50. PubMed ID: 14667218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.